Literature DB >> 16126219

The HLDA8 blind panel: findings and conclusions.

Bernadette Swart1, Mikhail P Salganik, Matthew P Wand, Kathryn Tinckam, Edgar L Milford, Karel Drbal, Pavla Angelisova, Vaclav Horejsi, Peter Macardle, Sheree Bailey, Enoc Hollemweguer, Greg Hodge, Judith Nairn, Debbrah Millard, Attila Dagdeviren, Geoffrey W Dandie, Heddy Zola.   

Abstract

There were over 600 antibodies submitted to HLDA8, with many of unknown specificity. Of these, 101 antibodies were selected for a blind panel study that also included 5 negative controls and 27 positive controls of known CD specificity making a total of 133 antibodies in the final panel. Of the 101 unknowns, 31 antibodies were identified during the course of this blind panel study as being specific for known molecules and included some specific for MHC class II antigens, CD45 isoforms and the Dombrock antigen. Several antibody pairs among those in the blind panel were found to have very similar staining patterns and were therefore compared by immunohistochemical and/or Western blot analyses for identity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126219     DOI: 10.1016/j.jim.2005.07.003

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  1 in total

1.  Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers.

Authors:  Craig Dorrell; Maria T Grompe; Fong Cheng Pan; Yongping Zhong; Pamela S Canaday; Leonard D Shultz; Dale L Greiner; Chris V Wright; Philip R Streeter; Markus Grompe
Journal:  Mol Cell Endocrinol       Date:  2011-04-22       Impact factor: 4.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.